| Literature DB >> 28571152 |
Biswajit Dey1, Debasis Gochhait2, Hema Subramanian3, Madhusudhanan Ponnusamy4.
Abstract
Oncogenic osteomalacia, also known as tumour induced osteomalacia, is a rare paraneoplastic syndrome caused by mesenchymal tumours secreting Fibroblast Growth Factor-23 (FGF-23). The characteristic biochemical findings include hypophosphatemia and low 1,25-dihydroxy vitamin D. The differential diagnosis for hypophosphatemia are varied. We present a case of oncogenic osteomalacia in a 29-year-old female, who presented with complaints of generalized diffuse bone pain and walking difficulty for six months duration. Thus, we have discussed the approach to diagnosis in such a case.Entities:
Keywords: Fibroblast growth factor-23; Phosphaturic mesenchymal tumour; Scintigraphy
Year: 2017 PMID: 28571152 PMCID: PMC5449798 DOI: 10.7860/JCDR/2017/25055.9634
Source DB: PubMed Journal: J Clin Diagn Res ISSN: 0973-709X